Tuesday, April 14, 2026 | 02:25 PM ISTहिंदी में पढें
Strides Pharma Science Ltd
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Re
06:26 PM, 13th Mar 2023
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on March 13 2023 for Pronomz Ventures LLP